Current price levels represent good timing for the opening of new short positions with respect to shares in Helmerich & Payne. The resistance zone around 47.4 USD could effectively set off a correction phase over the short term. Investors should open a short trade and target the $ 41.5.
In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
The company has poor fundamentals for a short-term investment strategy.
The company is in a robust financial situation considering its net cash and margin position.
Historically, the company has been releasing figures that are above expectations.
The company is one of the best yield companies with high dividend expectations.
Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
Low profitability weakens the company.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
With an expected P/E ratio at 71.52 and 63.93 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Revenue estimates are regularly revised downwards for the current and coming years.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the past year, analysts have significantly revised downwards their profit estimates.
Below the resistance at 48.4 USD, the stock shows a negative configuration when looking looking at the weekly chart.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.